Mortality following treatment for cannabis use disorders: Predictors and causes

7 de novembro de 20121min

Mikkel Arendt, MSc, PhD a, b,⁎, Povl Munk-Jørgensen, DMSc a, Leo Sher, MD b, Signe Olrik Wallenstein Jensen, MSc a

Cannabis is the most frequently used illicit substance in the world with lifetime use reported by almost half of young adults (15– 34 years) in the United States, Australia, and Canada, and 32% in the European Union (European Monitoring Centre for Drugs, Drug Addiction (EMCDDA) [EMCDDA], 2011; Substance Abuse and Mental Health Services Administration (SAMHSA) (SAMHSA), 2008).

It is estimated that 9% of those who use cannabis become dependent (Anthony, Warner, & Kessler, 1994). Among people seeking sub- stance abuse treatment for the first time in Europe, the proportion of those who reported cannabis as the main problem increased by 40% between 2004 and 2009 (EMCDDA, 2011)

pdf 1-s2.0-S0740547212003820-main_copia.pdf

Sobre a UNIAD

A Unidade de Pesquisa em álcool e Drogas (UNIAD) foi fundada em 1994 pelo Prof. Dr. Ronaldo Laranjeira e John Dunn, recém-chegados da Inglaterra. A criação contou, na época, com o apoio do Departamento de Psiquiatria da UNIFESP. Inicialmente (1994-1996) funcionou dentro do Complexo Hospital São Paulo, com o objetivo de atender funcionários dependentes.